Author

amgen has launched two pivotal late-stage trials for maritide, an experimental weight loss drug aimed at entering the growing obesity treatment market, competing against other products from novo nordisk and eli lilly.

Health Amgen starts two critical late-stage trials for weight loss drug MariTide
198 views
Happiness 😊

Happiness 😊 - 60%
60%
Anger 😡 - 10%
10%
Surprise 😲 - 30%
30%

Mentions in context

Author
😊 Happiness

amgen is conducting late-stage trials for its weight loss drug maritide.

Author
😊 Happiness

maritide is amgen's experimental weight loss injection currently in late-stage trials.

Author
😊 Happiness

amgen's executive vice president of research and development, spoke about the trials.

Author
😨 Fear

novo nordisk produces existing weight loss drugs that maritide aims to compete against.

Author
😨 Fear

eli lilly also manufactures weight loss drugs that compete with maritide.